Litcius/Paper detail

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra, José G. van den Berg, Arend G. J. Aalbers, Karolina Sikorska, Marta López‐Yurda, Cecile Grootscholten, Geerard L. Beets, Pétur Snæbjörnsson, Monique Maas, Marjolijn Mertz, Vivien Veninga, Gergana Bounova, Annegien Broeks, Regina G. H. Beets‐Tan, Thomas R. de Wijkerslooth, Anja U. van Lent, Hendrik A. Marsman, Elvira Nuijten, Niels F. M. Kok, Maria Kuiper, Wieke H.M. Verbeek, Marleen Kok, Monique E. van Leerdam, Ton N. Schumacher, Emile E. Voest, John B.A.G. Haanen

2020Nature Medicine1,391 citationsDOIOpen Access PDF

Topics & Concepts

NivolumabMedicineIpilimumabOncologyTremelimumabInternal medicineColorectal cancerImmunotherapyCancerCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesColorectal and Anal Carcinomas